Patch Graft Closure with Carotid Endarterectomy



Patch Graft Closure with Carotid Endarterectomy



Ali F. AbuRahma


Stroke is the third leading cause of death in the United States. Approximately 15% to 52% of all ischemic strokes are caused by extracranial cerebrovascular atherosclerotic lesions. It has also been estimated that 103,000 carotid endarterectomies (CEAs) were done in the United States in 2005.


Few procedures have been scrutinized as thoroughly as CEA during the last 2 decades. The Society of Vascular Surgery, in a special communication, and based on the results of several prospective randomized trials in North America and Europe that were designed to compare the safety and efficacy of CEA versus medical therapy, published outlines for managing atherosclerotic carotid artery disease that details recommendations for medical therapy versus CEA and carotid stenting for both symptomatic and asymptomatic carotid artery stenosis. Collectively, the data from these prospective trials have confirmed that CEA offers significantly better protection from ipsilateral strokes than medical therapy in a substantial number of patients presenting with either symptomatic or asymptomatic carotid artery disease.



Patch Closure Versus Primary Closure


The type of closure after a CEA, primary versus patch closure, remains controversial. Most authorities agree that in a small carotid artery (≤4 mm), particularly in the presence of technical difficulties at the internal carotid artery (ICA) end of the arteriotomy, closing with a patch can prevent restenosis. It is not uncommon for lateral tears to occur at the apex of the ICA after the linear arteriotomy is made, and patching can prevent narrowing during primary closure of the arteriotomy. In patients with excessive thickening of the intima of the distal ICA, patching can smooth the transition zone from the CEA site to the residual artery beyond. Patching might also be advisable in patients with kinked arteries, and it can help maintain the lumen and prevent postoperative occlusion. Patching should also be routinely used for redo CEA.


CEA with patch angioplasty is generally believed to decrease the chance of technical errors and has been shown by multiple clinical trials to be more effective than CEA with primary closure in decreasing the incidence of perioperative carotid thrombosis, perioperative stroke, and late restenosis. However, many others believe that inclusion of a patch prolongs the operative time and clamp or shunt time, makes the procedure technically more demanding, and is unnecessary in some patients.


In 1996, we published the largest prospective randomized trial comparing CEA with primary closure versus patching, where 264 CEAs were done with patching (130 vein patch closures and 134 polytetrafluoroethylene [PTFE] patch closures) and 135 CEAs were done with primary closure. The perioperative stroke or death rates were 2.3% for patching versus 6.7% for primary closure (odds ratio [OR], 0.3; 95% confidence interval [CI], 0.1–0.88), and the 50% or greater restenosis rates at 30 months were 5.3% for patching versus 33% for primary closure (OR, 0.11; CI, 0.06–0.19).


In another unique randomized trial, we analyzed 74 patients undergoing bilateral sequential CEAs. Patients were randomized to either patching in the first CEA then primary closure in the second CEA or primary closure in the first and patching in the second; that is, each patient was his or her own control. Primary closure had an ipsilateral stroke rate of 4% versus 0% for CEA with patching, and at a late mean follow-up of 29 months, the incidence of at least 80% restenosis was significantly higher in the primary closure group.


Several randomized, controlled trials (Level I evidence) have been published since the 1990s comparing CEA with patch angioplasty versus primary closure. Table 1 summarizes the results of these randomized, controlled trials. As noted in this table, these trials showed the superiority of patch closure over primary closure in reducing the perioperative stroke or death and the incidence of significant restenosis.



TABLE 1


Results of Randomized, Controlled Trials of Carotid Endarterectomy with Patch Closure versus Primary Closure





























































































Reference No. Patch/
Primary
Perioperative Stroke/Death (%)
Patch/
Primary
Odds Ratio (95% CI) ≥50% Restenosis Rate (%)
Patch/
Primary
Odds Ratio (95% CI) Follow-Up (mo.)
De Vleeschauwer, 1987 90/84 0/0 N/A 1.1/10.7 0.1 (0.0–0.8) 12
Eikelboom, 1988 66/60 4.5/6.7 0.67 (0.15–3.06) 11.9/27.4 0.37 (0.16–0.89) 60
Lord, 1989 90/50 1.1/6.0 0.2 (0.0–1.7) N/A N/A Hospital discharge
Ranaboldo, 1993 96/91 3.2/7.7 0.41 (0.11–1.45) 5.5/16.3 0.33 (0.14–0.77) 12
Myers, 1994 46/48 0/2.1 0.14 (0.00–7.12) 3.2/3.1 1.03 (0.14–7.51) 54
Katz, 1994 43/44 2.3/4.5 0.52 (0.05–5.11) 0/5.9 0.14 (0.01–1.33) 29
AbuRahma, 1998 264/135 2.3/6.7 0.3 (0.10–0.88) 5.3/33.3 0.11 (0.06–0.19) 30
AbuRahma, 1999 74/74 0/4.0 NA 7/45 0.09 (0.03–0.25) 29
Bond, 2004
(Cochrane review)
515/378 2.5/6.1 0.40 (0.2–0.8) 4.8/18.6 0.22 (0.1–0.3) N/A
Al-Rawi, 2006 153/175 4.0/2.9 1.39 (0.42–4.64) 3.3/1.7 1.9 (0.46–8.24) 12


image


CI, Confidence interval; N/A, not available or not applicable.


Includes 30-day risk of ipsilateral stroke only.


This is a meta-analysis of several randomized trials.


Carotid occlusion only (not ≥50% restenosis).



AbuRahma AF, Robinson PA, Saiedy S, et al: Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up, J Vasc Surg 27:222–234, 1998.


AbuRahma AF, Robinson PA, Saiedy S, et al: Prospective randomized trial of bilateral carotid endarterectomies: primary closure versus patching, Stroke 30:1185–1189, 1999.


Bond R, Rerkasem K, Naylor AR, et al: Systematic review of randomized controlled trials of patch angioplasty versus primary closure and different patch materials during carotid endarterectomy, J Vasc Surg 40:1126–1135, 2004.


Lord RSA, Raj TB, Stary DL, et al: Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: perioperative results, J Vasc Surg 9:521–529, 1989.


In addition, there were two meta-analyses of the randomized, controlled carotid trials by the Cochrane Collaboration in 2000 and 2004. In an earlier Cochrane meta-analysis of randomized carotid trials, the early postoperative thrombosis, postoperative stroke, and at least 50% restenosis were superior for patching, in contrast to primary closure. In an update of the Cochrane Collaboration meta-analysis in 2004, Bond and colleagues reported the outcome for 1281 patients, including seven controlled carotid trials. Patch angioplasty was associated with a reduction in ipsilateral stroke (1.6% versus 4.8% for primary closure, p = .001), any stroke (1.6% vs. 4.5%, p = .004), stroke or death (2.5% vs. 6.1%, p = .007), arterial occlusion (0.5% vs. 3.6%, p = .0001), and return to the operating room (1.1% vs. 3.1%, p = .01). In long-term follow-up, patch angioplasty was also superior to primary closure in the reduction of ipsilateral stroke (1.6% vs. 4.8%, p = .001), any stroke (1.9% vs. 5.9%, p = .0009), stroke or death (14.6% vs. 24%, p = .004), and late restenosis (4.8% vs. 18.6%, p < .0001) (Figure 1).


Stay updated, free articles. Join our Telegram channel

Aug 25, 2016 | Posted by in CARDIOLOGY | Comments Off on Patch Graft Closure with Carotid Endarterectomy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access